Sunshine Guojian Pharmaceutical Co., Ltd. (688336)
SSE
40.48
+0.15 (+0.37%)
Closed
Sep 18, 2026
Day's Range
40.0041.17
52 wk Range
34.3466.62
Financial Statements - 688336 - Sunshine Guojian Pharmaceutical Co., Ltd.
Revenue
4.19B▲ 251.8%
Net Income
2.89B▲ 318.3%Net Margin 68.9%
EBITDA
3.39B▲ 320.0%
Free Cash Flow
2.79B▲ 787493.6%
Income Statement
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|---|---|
| Sales | 4.19B | 1.19B | 1.01B | 825.49M | 928.80M | 655M |
| Cost of Goods | 332.95M | 304.34M | 224.10M | 201.20M | 210.02M | 102.28M |
| Gross Profit | 3.86B | 889.22M | 789.92M | 624.29M | 718.78M | 552.71M |
 Operating Expense | - | - | - | - | - | - |
| Operating Income | 3.15B | 250.61M | 211.94M | 5.04M | -73.30M | -217.88M |
| Non-Operating Interest | - | - | - | - | - | - |
| Other Income Expense | - | - | - | - | - | - |
| Pre Tax Income | 3.31B | 707.65M | 310.63M | 28.95M | -53.38M | -282.40M |
| Income Tax | 426.68M | 16.26M | 27.27M | -16.47M | -51.69M | -46.59M |
| Net Income | 2.89B | 691.39M | 283.35M | 45.43M | -1.69M | -235.81M |
| EPS Basic | 3.241379 | 1.14 | 0.48 | 0.08 | 0.03 | -0.37 |
| EPS Diluted | 3.227586 | 1.14 | 0.48 | 0.08 | 0.03 | -0.37 |
| Basic Shares Outstanding | 894.46M | 618.05M | 613.78M | 616.21M | 601.95M | 587.73M |
| Diluted Shares Outstanding | 894.46M | 618.05M | 613.78M | 616.21M | 601.95M | 587.73M |
| Ebit | 3.31B | 708.83M | 312.03M | 30.27M | -73.30M | -217.88M |
| Ebitda | 3.39B | 807.87M | 324.46M | 127.27M | 52.15M | -97.33M |
| Net Income Continuous Operations | 2.89B | 691.39M | 283.35M | 45.43M | -1.69M | -235.81M |
| Minority Interests | 7.44M | 13.18M | 11.25M | 3.86M | 19.75M | 18.35M |
| Preferred Stock Dividends | 0 | 0 | 0 | 0 | 0 | 0 |
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
